NCT03828149View on ClinicalTrials.gov

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

March 7, 2019

Study Completion Date

March 7, 2019

Conditions
Healthy Adults
Interventions
COMBINATION_PRODUCT

Drug:OP0201

Drug: OP0201

COMBINATION_PRODUCT

Drug: Placebo

Drug: Placebo

Trial Locations (1)

50937

Cologne University Hospital, Cologne

Sponsors
All Listed Sponsors
lead

Novus Therapeutics, Inc

INDUSTRY